Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc., as indicated in the metadata) on June 3, 2010. The report discloses the issuance of a press release regarding financial results for the fiscal quarter and fiscal year ended March 31, 2010.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are referenced as being contained within the press release furnished as Exhibit 99.1, which is not included in the input text.
Material Changes
The filing does not provide specific data to compare current period results against prior comparable periods. The document serves solely as a notification that results for the period ended March 31, 2010, have been announced.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It strictly references the existence of the press release (Exhibit 99.1) for the full announcement.
Investor Verification Checklist
- Verify the correct registrant name is Oculus Innovative Sciences, Inc., not Sonoma Pharmaceuticals, Inc.
- Locate and review Exhibit 99.1 (the press release) to obtain actual financial figures for the quarter and year ended March 31, 2010.
- Confirm the fiscal year-end date is March 31, 2010, for accurate period comparison.